Ayurvedic Drug Zingivir-H Tab Gets Nod For Clinical Trials

PSM News /

KOCHI, 4 may 2020:

 

An ayurvedic medicine, Zingivir-H tablet, used for treating respiratory infections has got approval from the Clinical Trial Registry of India (CTRI) for clinical trials on adults who have tested positive for Covid-19. CTRI comes under the Indian Council of Medical Research (ICMR).

 

The drug, developed by Kerala-based Pankajakasthuri Herbal Research, will now be tested as a potential medicine for Covid-19 in medical colleges in India. ET HealthWorld